Jiangsu Lianhuan Pharmaceutical Co., Ltd. (600513.SS)
CNY 10.22
(0.89%)
CNY 10.22
(0.89%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 160.7 Million | 127.59 Million | 138.34 Million | 91.93 Million | -9.86 Million | -92 Million |
| Net Income | 151.34 Million | 166.44 Million | 139.9 Million | 120.15 Million | 83.24 Million | 74.16 Million |
| Depreciation & Amortization | 56.48 Million | 40.8 Million | 28.05 Million | 22.09 Million | 20.24 Million | 22.45 Million |
| Deferred income taxes | -3.33 Million | -11.87 Million | 999.52 Thousand | 1.71 Million | -1.32 Million | -1.34 Million |
| Stock-based compensation | -4.24 Million | 1.2 Million | 1.37 Million | 2.9 Million | 1.5 Million | - |
| Change in working capital | -68.98 Million | -117.07 Million | -52.27 Million | -75.5 Million | -129 Million | -199.3 Million |
| Other non-cash items | 21.87 Million | 48.08 Million | 20.28 Million | 20.56 Million | 15.44 Million | 10.68 Million |
| Investing Cash Flow | -184.69 Million | -220.68 Million | -177.43 Million | -129.23 Million | -180.58 Million | -49.25 Million |
| Investments in PPE | -200.66 Million | -209.01 Million | -168.92 Million | -174.17 Million | -168.63 Million | -128.35 Million |
| Acquisitions | -1.74 Million | 4.41 Million | -5.91 Million | 518.19 Thousand | -24.33 Million | 87.46 Million |
| Investment purchases | -10.75 Million | - | 5.91 Million | 22.02 Million | - | - |
| Sales/Maturities of investments | 2 Million | - | 60.84 Thousand | 69.76 Thousand | - | 750 Thousand |
| Other Investing Activities | 26.47 Million | -16.07 Million | -8.57 Million | 22.33 Million | 12.38 Million | 78.34 Million |
| Financing Cash Flow | -35.09 Million | 76.92 Million | 141.55 Million | 13.51 Million | 192.77 Million | 789.28 Thousand |
| Debt repayment | -630.05 Million | -662.8 Million | -375 Million | -339 Million | -146.82 Million | -88.5 Million |
| Dividends payments | -43.07 Million | -35.89 Million | -31.1 Million | -24.19 Million | -22.26 Million | -27.83 Million |
| Common Stock Repurchased | -6.25 Million | -3.36 Million | - | -479.78 Thousand | - | - |
| Common Stock Issuance | 6.25 Million | 3.36 Million | - | 479.78 Thousand | - | - |
| Other Financing Activities | 646.17 Million | 794.12 Million | 556.34 Million | 395.02 Million | 370.87 Million | 117.11 Million |
| Accounts receivables | -47.39 Million | -130.55 Million | -56.96 Million | -121.13 Million | -178.97 Million | -178.36 Million |
| Accounts payables | 20.35 Million | 102.65 Million | 16.36 Million | 3.21 Million | 113.7 Million | 30.78 Million |
| Inventory | -38.61 Million | -77.3 Million | -12.67 Million | 40.7 Million | -62.4 Million | -50.38 Million |
| Other working capital | -3.33 Million | -11.87 Million | 999.52 Thousand | 1.71 Million | -1.32 Million | -148.91 Million |
| Cash at beginning of period | 309.04 Million | 322.9 Million | 221.23 Million | 246.66 Million | 244.13 Million | 384.23 Million |
| Cash at end of period | 250.19 Million | 309.04 Million | 322.9 Million | 221.23 Million | 246.66 Million | 244.13 Million |
| Capital Expenditure | -200.66 Million | -209.01 Million | -168.92 Million | -174.17 Million | -168.63 Million | -128.35 Million |
| Effect of forex changes on cash | 232.22 Thousand | 2.31 Million | -789.45 Thousand | -1.64 Million | 211.07 Thousand | 374.26 Thousand |
| Net cash flow / Change in cash | -58.85 Million | -13.85 Million | 101.67 Million | -25.43 Million | 2.52 Million | -140.09 Million |
| Free Cash Flow | -39.96 Million | -81.42 Million | -30.57 Million | -82.24 Million | -178.5 Million | -220.35 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 29.81 Million | 30.34 Million | 32.54 Million | 46.16 Million | 151.34 Million | 27.31 Million |
| Depreciation & Amortization | - | 15.3 Million | 15.3 Million | 14.89 Million | 56.48 Million | -27.46 Million |
| Deferred income taxes | - | - | - | 94.49 Million | -3.33 Million | -89.6 Million |
| Stock-based compensation | - | - | - | -4.24 Million | -4.24 Million | 1.56 Million |
| Change in working capital | - | -120.11 Million | - | -90.24 Million | -68.98 Million | 115.5 Million |
| Other non-cash items | 21.69 Million | -24.6 Million | -50.42 Million | 204.77 Million | 21.87 Million | -43.37 Million |
| Investing Cash Flow | -19.87 Million | -81.46 Million | -34.57 Million | -52.99 Million | -184.69 Million | -31.62 Million |
| Investments in PPE | -19.87 Million | -81.46 Million | -34.57 Million | -53.6 Million | -200.66 Million | -46.37 Million |
| Acquisitions | 700.00 | - | - | -1.5 Million | -1.74 Million | 23.5 Million |
| Investment purchases | - | - | - | 600 Thousand | -10.75 Million | -8.75 Million |
| Sales/Maturities of investments | - | - | - | 1318.45 | 2 Million | -23.5 Million |
| Other Investing Activities | 700.00 | - | - | 1.51 Million | 26.47 Million | 23.5 Million |
| Financing Cash Flow | 29.32 Million | 22.77 Million | 887.1 Thousand | -43.8 Million | -35.09 Million | 34.9 Million |
| Debt repayment | -34.9 Million | -73.18 Million | -6.22 Million | -245.45 Million | -630.05 Million | -112.6 Million |
| Dividends payments | -5.48 Million | -32.73 Million | -5.33 Million | -43.07 Million | -43.07 Million | -5.29 Million |
| Common Stock Repurchased | - | - | - | -6.25 Million | -6.25 Million | - |
| Common Stock Issuance | - | - | - | 6.25 Million | 6.25 Million | - |
| Other Financing Activities | -92.74 Thousand | -50.28 Million | -5.33 Million | 208.68 Million | 646.17 Million | 152.79 Million |
| Accounts receivables | - | -61.13 Million | - | -47.39 Million | -47.39 Million | 68.06 Million |
| Accounts payables | - | - | - | - | 20.35 Million | -1.56 Million |
| Inventory | - | -58.97 Million | - | -38.61 Million | -38.61 Million | 47.43 Million |
| Other working capital | - | - | - | -4.24 Million | -3.33 Million | 1.56 Million |
| Cash at beginning of period | 130.37 Million | 198.63 Million | 250.19 Million | 175.83 Million | 309.04 Million | 188.55 Million |
| Cash at end of period | 191.41 Million | 130.37 Million | 198.63 Million | 250.19 Million | 250.19 Million | 175.83 Million |
| Capital Expenditure | -19.87 Million | -81.46 Million | -34.57 Million | -53.6 Million | -200.66 Million | -46.37 Million |
| Effect of forex changes on cash | 84.45 Thousand | - | 19.06 Thousand | -189.8 Thousand | 232.22 Thousand | 61.79 Thousand |
| Net cash flow / Change in cash | 61.03 Million | -68.26 Million | -51.55 Million | 74.35 Million | -58.85 Million | -12.72 Million |
| Free Cash Flow | 31.62 Million | -91.04 Million | -52.45 Million | 117.73 Million | -39.96 Million | -62.43 Million |
SITAENT
601000
3989
ABSI
603238
PRLH